NLM Logo

COVID-19 MeSH Descriptor Data 2023


MeSH Heading
COVID-19
Tree Number(s)
C01.748.610.763.500
C01.925.705.500
C01.925.782.600.550.200.163
C08.381.677.807.500
C08.730.610.763.500
Unique ID
D000086382
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000086382
Scope Note
A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
Entry Term(s)
2019 Novel Coronavirus Disease
2019 Novel Coronavirus Infection
2019-nCoV Disease
2019-nCoV Infection
COVID-19 Pandemic
COVID-19 Pandemics
COVID-19 Virus Disease
COVID-19 Virus Infection
COVID19
Coronavirus Disease 2019
Coronavirus Disease-19
SARS Coronavirus 2 Infection
SARS-CoV-2 Infection
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
See Also
SARS-CoV-2
Public MeSH Note
2021; for COVID-19 see PNEUMONIA, VIRAL; CORONAVIRUS INFECTIONS; and PANDEMICS 2020
History Note
2021(2020)
Entry Combination
drug therapy:COVID-19 Drug Treatment
Date Established
2021/01/01
Date of Entry
2020/07/07
Revision Date
2022/07/14
COVID-19 Preferred
COVID-19 Pandemic Related
page delivered in 0.163s